All data are based on the daily closing price as of November 20, 2025
t
Towa Pharmaceutical
4553.TSE
19.08 USD
-0.13
-0.68%
Overview
Last close
19.08 usd
Market cap
939.40M usd
52 week high
23.11 usd
52 week low
16.24 usd
Target price
24.68 usd
Valuation
P/E
7.2015
Forward P/E
16.7785
Price/Sales
0.5575
Price/Book Value
0.8107
Enterprise Value
2.12B usd
EV/Revenue
1.2469
EV/EBITDA
6.4701
Key financials
Revenue TTM
1.70B usd
Gross Profit TTM
617.14M usd
EBITDA TTM
283.56M usd
Earnings per Share
2.67 usd
Dividend
0.25 usd
Total assets
3.25B usd
Net debt
1.16B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.